コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ISTANCE8 (PDR8), a highly expressed putative ATP binding cassette transporter.
2 upled to the movement of peptide through the ATP-binding cassette transporter.
3 bility to efflux DNA binding dyes through an ATP-binding cassette transporter.
4 s from the evolutionary origin of CFTR as an ATP-binding cassette transporter.
5 r (CFTR) is an anion channel evolved from an ATP-binding cassette transporter.
6 smid-encoded GldF, a component of a putative ATP-binding cassette transporter.
7 ipped to the periplasmic leaflet by MsbA, an ATP-binding cassette transporter.
8 aracteristic glycan export step involving an ATP-binding cassette transporter.
9 P), a liver-specific adenosine triphosphate (ATP)-binding cassette transporter.
10 fficked to the plasma membrane for export by ATP-binding cassette transporters.
11 ain microdomains enriched in cholesterol and ATP-binding cassette transporters.
12 gulatory insertion (RI) not present in other ATP-binding cassette transporters.
13 s from bacterial phosphite and hypophosphite ATP-binding cassette transporters.
14 ary for vectorial transport of substrates in ATP-binding cassette transporters.
15 pleiotropic drug resistance (PDR) family of ATP-binding cassette transporters.
16 inesterases, glutathione-S-transferases, and ATP-binding cassette transporters.
17 d its orthologs, or from structures of other ATP-binding cassette transporters.
18 o study substrate specificity of peroxisomal ATP-binding cassette transporters.
19 o deliver cargo to plasma membrane-localized ATP-binding cassette transporters.
20 previously unknown regulatory mechanism for ATP-binding cassette transporters.
21 its, with dimensions characteristic of other ATP-binding cassette transporters.
23 duced Niemann-Pick C1-like 1 (NPC1L1), CD36, ATP-binding cassette transporter 1 (ABCA1), and ABCG8 le
24 y, expression of the cholesterol efflux pump ATP-binding cassette transporter 1 (ABCA1), which is reg
27 elic variants of apolipoprotein E (APOE) and ATP-binding cassette transporter-1 (ABCA1), two genes in
28 liver X receptor (LXR)-alpha, LXR-beta, and ATP-binding cassette transporter-1, which results in dec
32 thesized that multidrug resistance protein 4/ATP binding cassette transporter 4 (MRP4/ABCC4), a widel
33 Here we report that mice lacking both the ATP-binding cassette transporter 4 (Abca4) and enzyme re
34 in cone-rod dystrophy (CORD) of mice lacking ATP-binding cassette transporter 4 (ABCA4) and retinol d
35 clearance resulting from the absence of both ATP-binding cassette transporter 4 (Abca4) and retinol d
36 rogenase 8 (RDH8) and photoreceptor-specific ATP-binding cassette transporter 4 (ABCA4), in dark adap
37 etinal, namely photoreceptor-specific ABCA4 (ATP-binding cassette transporter 4) and RDH8 (retinol de
38 uman RPE/choroid, eyes harvested from Abca4 (ATP-binding cassette transporter 4) null mutant mice, an
39 ndant in mice with a null mutation in Abca4 (ATP-binding cassette transporter 4), the gene causative
40 x and levels of the cholesterol transporters ATP binding cassette transporter A1 (ABCA1) and ABCG1.
41 oER2-mediated signaling on the expression of ATP binding cassette transporter A1 (ABCA1) and choleste
42 chain positively regulates the expression of ATP binding cassette transporter A1 (ABCA1) and of neutr
45 olesterol reservoir and abundantly expresses ATP binding cassette transporter A1 (ABCA1), a key chole
46 f the major cellular cholesterol transporter ATP binding cassette transporter A1 (ABCA1), suggesting
47 ligands for both receptor subtypes activate ATP binding cassette transporter A1 (ABCA1)-mediated cho
49 aining nascent HDL particles produced by the ATP binding cassette transporter A1 have different sizes
50 nce of scavenger receptor class B type I and ATP Binding Cassette Transporter A1, but not the ATP Bin
51 roid receptor element-binding protein 1c and ATP binding cassette transporter A1, demonstrating HSL-d
53 erbated by down-modulation and impairment of ATP-binding cassette transporter A1 (ABCA1) activity by
54 Genetic deletion of the sterol transporters ATP-binding cassette transporter A1 (ABCA1) and low-dens
55 rotein levels of apolipoprotein E (apoE) and ATP-binding cassette transporter A1 (ABCA1) being highly
56 ell lipid:apoAI ratio due to either elevated ATP-binding cassette transporter A1 (ABCA1) expression a
57 levels associated with increased enterocyte ATP-binding cassette transporter A1 (Abca1) expression a
58 -secretase 1 (BACE1) and an up-regulation of ATP-binding cassette transporter A1 (ABCA1) expression,
60 ess lower levels of the cholesterol exporter ATP-binding cassette transporter A1 (ABCA1) in compariso
61 omal triglyceride transfer protein (MTP) and ATP-binding cassette transporter A1 (ABCA1) in these pat
62 port proteins cholesterol 27-hydroxylase and ATP-binding cassette transporter A1 (ABCA1) in THP-1 cel
66 diated via liver-X receptor alpha (LXRalpha)/ATP-binding cassette transporter A1 (ABCA1) pathway, as
67 promote cholesterol efflux from cells by the ATP-binding cassette transporter A1 (ABCA1) pathway.
68 of HDL to remove cellular cholesterol by the ATP-binding cassette transporter A1 (ABCA1) pathway.
71 ations in the cholesterol efflux transporter ATP-binding cassette transporter A1 (ABCA1) result in im
73 nd very low HDL, resulting from mutations in ATP-binding cassette transporter A1 (ABCA1), an integral
75 involved in lipid metabolism, including the ATP-binding cassette transporter A1 (ABCA1), have been a
77 poA1 Trp72 in MPO-mediated inhibition of the ATP-binding cassette transporter A1 (ABCA1)-dependent ch
78 -containing nascent HDL particles created by ATP-binding cassette transporter A1 (ABCA1)-mediated eff
85 f the reverse cholesterol transport factors, ATP-binding cassette transporter A1 and high-density lip
86 lly, miR-223 was found to indirectly promote ATP-binding cassette transporter A1 expression (mRNA and
87 or-activated receptor-gamma/liver X receptor/ATP-binding cassette transporter A1 pathway in macrophag
89 creased scavenger receptor B1, and unchanged ATP-binding cassette transporter A1 protein expression i
90 was mediated through up-regulation of ABCA1 (ATP-binding cassette transporter A1) protein expression.
91 ed expression of LXR target genes, including ATP-binding cassette transporter A1, and increased apoli
92 pholipid transfer protein) and cell factors (ATP-binding cassette transporter A1, ATP-binding cassett
93 dual mechanism that required a reduction in ATP-binding cassette transporter A1-mediated (ABCA1-medi
94 gs suggest that niacin by increasing hepatic ATP-binding cassette transporter A1-mediated apoAI lipid
95 plets or shuttled to the plasma membrane for ATP-binding cassette transporter A1-mediated efflux.
96 liver X receptor-responsive genes including ATP-binding cassette transporters A1 (ABCA1) and G1 (ABC
98 eveloped mice with efficient deletion of the ATP-binding cassette transporters A1 and G1 (ABCA1 and A
103 ATPase activity of the human retina specific ATP binding cassette transporter (ABC), ABCR, by nucleot
104 dation of some, but not all, plasma membrane ATP-binding cassette transporters (ABC), including the c
106 l efflux pathways due to deficiencies of the ATP binding cassette transporters ABCA1 and ABCG1 displa
107 sterol in association with downregulation of ATP-binding cassette transporter ABCA1 occurs in normal
110 ts involvement in cholesterol efflux via the ATP-binding cassette transporters ABCA1 and ABCG1, which
111 ges and is significantly associated with the ATP-binding cassette transporters ABCA1 and ABCG1, which
113 olesterol transport through up-regulation of ATP-binding cassette transporters (ABCA1 and ABCG1) that
114 e important pathway is a membrane-associated ATP-binding cassette transporter, ABCA1, that clears cho
115 ere generated by conditional deletion of the ATP-binding cassette transporters, ABCA1 and ABCG1, in b
116 ious studies have focused on the role of the ATP-binding cassette transporter ABCA4 associated with S
117 the all-trans-RDHs, Rdh8 and Rdh12, and the ATP-binding cassette transporter Abca4, retinoid cycle e
118 otoreceptor-specific adenosine triphosphate (ATP)-binding cassette transporter (ABCA4) protein that i
119 rogenase 8 (RDH8) and photoreceptor-specific ATP-binding cassette transporter (ABCA4) accelerate the
126 spholipase A2, pumped out of the cell by the ATP-binding cassette transporter ABCC1/MRP1, and is then
128 gates, a single candidate gene (encoding the ATP-binding cassette transporter ABCC6) was identified.
137 codes the transmembrane domain of a putative ATP-binding cassette transporter, affords resistance to
141 by the energy of ATP binding and hydrolysis, ATP-binding cassette transporters alternate between inwa
142 ne-resident pleiotropic drug resistance-type ATP-binding cassette transporter and is thought to act i
143 erentiates the human CFTR channel from other ATP-binding cassette transporters and exerts multiple ef
144 the SP cells indicated higher expression of ATP-binding cassette transporters and genes involved in
145 mplement substrate-binding proteins from the ATP-binding cassette transporters and multidomain extrac
148 ytochrome P450, gluthathione S-transferases, ATP-binding cassette transporters, and a gene that confe
149 esistance-associated protein (MRP) subfamily ATP-binding cassette transporters are able to transport
150 and therapies, substrate binding proteins of ATP-binding cassette transporters are important targets.
157 l cell, thus further implicating CFTR as the ATP-binding cassette transporter associated with the K(A
158 s candidate genes, glycogen synthase (glys), atp-binding cassette transporter (atp), and low-density
159 c metabolite profile in Abcb6 (mitochondrial ATP-binding cassette transporter B6) deficiency results
160 -kDa protein complex LptB2FG is unique among ATP-binding cassette transporters because it extracts li
161 inase Pim-1 phosphorylates and activates the ATP-binding cassette transporter breast cancer resistanc
162 , the heteromeric adenosine 5'-triphosphate (ATP)-binding cassette transporter BtuC2D2, we can mainta
163 ductance regulator (CFTR) is a member of the ATP-binding cassette transporters but serves as a chlori
165 This is the first demonstration that an ATP-binding cassette transporter can affect in vivo tiss
166 e nucleotide-binding domain, suggesting that ATP-binding cassette transporters catalyze ATP hydrolysi
167 report, we demonstrate that the peroxisomal ATP-binding cassette transporter COMATOSE is required fo
168 While TGD1, TGD2, and TGD3 constitute an ATP binding cassette transporter complex residing in the
171 n this study, we describe the broad-spectrum ATP-binding cassette transporter CpMRP of the poplar lea
172 e integration intermediates derived from the ATP-binding cassette transporter cystic fibrosis transme
173 el for glycan biosynthesis and export by the ATP-binding cassette transporter-dependent pathway.
175 des from Gram-negative bacteria, produced by ATP-binding cassette transporter-dependent pathways, are
176 biosynthesis of bacterial polysaccharides by ATP-binding cassette transporter-dependent pathways.
177 for the biosynthesis of O polysaccharides by ATP-binding cassette transporter-dependent processes.
178 ins, cellular efflux of a known substrate of ATP-binding-cassette transporters, doxorubicin (a fluore
179 to drive normal levels of expression of the ATP-binding cassette transporter-encoding gene PDR5 in S
181 e identify awake1 as an allele of ABCG20, an ATP-binding cassette transporter-encoding gene required
188 MDR is often the result of overexpression of ATP-binding cassette transporters following chemotherapy
190 lities of one of the smallest subfamilies of ATP-binding cassette transporters from Arabidopsis thali
202 s other cholesterol export proteins (such as ATP-binding cassette transporter G1 and apolipoprotein E
203 that ATP-binding cassette transporter A1 and ATP-binding cassette transporter G1 are involved in macr
204 ATP-binding cassette transporter A1 and ATP-binding cassette transporter G1 are liver X receptor
205 s of ATP-binding cassette transporter A1 and ATP-binding cassette transporter G1 in macrophage revers
206 his pathway, including the importance of the ATP-binding cassette transporter G1 in macrophages and a
208 actors (ATP-binding cassette transporter A1, ATP-binding cassette transporter G1, scavenger receptor
216 ze with genes encoding beta-glucosidases and ATP-binding cassette transporters, highlighting a probab
219 ion of p-glycoprotein (P-gp), a subfamily of ATP-binding cassette transporter in a concentration- and
221 nctional in cystic fibrosis, is unique among ATP-binding cassette transporters in that it functions a
223 Energy coupling factor (ECF) proteins are ATP-binding cassette transporters involved in the import
225 show, however, that the LpqY-SugA-SugB-SugC ATP-binding cassette transporter is highly specific for
227 toplasmic pathway, found closed off in other ATP-binding cassette transporters, is cracked open, cons
228 face proteins IsdA, IsdB, IsdC, and IsdH and ATP-binding cassette transporter IsdDEF, constitute the
229 h encodes a digestive vacuole membrane-bound ATP-binding cassette transporter known to alter P. falci
233 nce-associated protein 2 (Mrp2, Abcc2) is an ATP-binding cassette transporter localized at the canali
236 mbrane protein MalF (MalF-P2) of the maltose ATP-binding cassette transporter (MalFGK(2)-E) as an imp
238 Ester Transfer Protein (CETP) inhibition and ATP-binding cassette transporter member 1 (ABCA1) up-reg
240 ap junction channel protein connexin 26, the ATP binding cassette transporter MsbA, the seven-transme
241 stal structures of the bacterial homodimeric ATP-binding cassette transporters MsbA from gram-negativ
243 we measured the effect of MSC EV on a known ATP-binding cassette transporter, multidrug resistance-a
244 Double-mutant analysis with the peroxisomal ATP-binding cassette transporter mutant peroxisomal ABC
247 This is the first demonstration that an ATP-binding cassette transporter other than P-glycoprote
254 s commonly acquired by overexpression of the ATP binding cassette transporter, P-glycoprotein (P-gp).
255 Arabidopsis penetration resistance 3 (PEN3) ATP binding cassette transporter participates in nonhost
256 cation machineries, the peptidase-containing ATP-binding cassette transporters (PCATs) are appealingl
259 E9 (PDR9/ABCG37/At3g53480), which encodes an ATP-binding cassette transporter previously implicated i
261 s from loss of normal activity of a vacuolar ATP-binding cassette transporter protein called Ycf1.
264 nstrated that loss of the genes encoding the ATP-binding cassette transporter proteins Pdr5 and Yor1
265 aused by the expression or overexpression of ATP-binding cassette transporter proteins such as the mu
266 U, along with the high-affinity, Pi-specific ATP-binding cassette transporter PstSCAB and the two-com
268 ldA, gldF, and gldG) that encode an apparent ATP-binding cassette transporter required for F. johnson
270 and tonoplast in a manner characteristic of ATP-binding cassette transporters, similar to those that
271 e two-color MRP1 construct for investigating ATP-binding cassette transporter structural dynamics, an
272 ations affecting the cholesterol transporter ATP-binding cassette transporter subfamily A member 1 (A
280 TRATION3/ABCG36, a plasma membrane-localized ATP binding cassette transporter that has established ro
285 components of the protein bridge comprise an ATP-binding cassette transporter that powers transport,
286 et is a prototypic, plasma membrane resident ATP-Binding Cassette transporter that pumps xenobiotic c
288 d ABCA4 are members of the ABCA subfamily of ATP-binding cassette transporters that share extensive s
289 nd interactions with purified P-gp and other ATP-binding cassette transporters that transport amphipa
291 D1, -2, and -3 proteins form a putative ABC (ATP-binding cassette) transporter transporting ER-derive
292 es the abundance of cholesterol transporter, ATP-binding cassette transporter type A1 (ATP-binding ca
293 r, ATP-binding cassette transporter type A1 (ATP-binding cassette transporter type A1), but reduces c
295 e, fructose, sucrose, and trehalose, whereas ATP-binding cassette transporters were identified for up
299 revisiae bearing precise deletions of all 16 ATP-binding cassette transporters within clades associat